Loading viewer...
conference
Format: PDF conference
Karyopharm Therapeutics presented at the HC Wainwright 26th Annual Global Investment Conference in September 2024, discussing selinexor (XPOVIO) development and commercialization. The presentation covers the company's refinancing transactions, 2024 financial guidance, and clinical development plans for selinexor across multiple myeloma, endometrial cancer, myelofibrosis, and diffuse large B-cell lymphoma.
conference
80 Pages
conference
26 Pages
AZZ
Cyprus Banking Sector 2024: Resilience, Compliance, Growth
conferenceconference
32 Pages
Cyprus Banking Sector / Central Bank of Cyprus
Regency Centers 2017 Citi Global Property CEO Conference
conferenceconference
11 Pages
Regency Centers Corporation